Results 161 to 170 of about 24,710 (219)

Ozoralizumab shows effectiveness regardless of baseline RF and ACPA titres in patients with RA: a post hoc analysis of the OHZORA trial. [PDF]

Rheumatology (Oxford)
Watanabe R, Tanaka Y, Takeuchi T, Okamoto S, Kyuuma M, Matsumoto R, Nakayama Y, Katsushima M, Hashimoto M.   +8 more
europepmc   +1 more source

Rheumatoid Lung Disease. [PDF]

Mediterr J Rheumatol
Drosos AA, Zikou AK, Yerolatsite M, Voulgari PV.   +3 more
europepmc   +1 more source

Preclinical assessment of two FcγRI-specific antibodies that competitively inhibit immune complex-FcγRI binding to suppress autoimmune responses. [PDF]

Nat Commun
Holtrop T, Brandsma AM, Feitsma LJ, Krohn S, Moerer P, van den Haak F, Versnel A, Voss L, Passchier EM, Nederend M, Jansen JHM, van Mourik AG, Urbanus RT, van der Woude D, Schutgens REG, Toes REM, Janssen BJC, Lux A, Budding K, Peipp M, Leusen JHW.   +20 more
europepmc   +1 more source

RA-risk synovium exhibits DNA damage coupled with impaired DNA repair in fibroblasts. [PDF]

RMD Open
O'Byrne AM, de Jong TA, Semmelink JF, Krawczyk PM, Hoebe RA, van de Sande M, van Baarsen L.   +6 more
europepmc   +1 more source

Janus Kinase Inhibitor Discontinuation at a UK Tertiary Centre: A Retrospective Study. [PDF]

Cureus
Bland K, Jubber A, Ganguly S, Moorthy A.
europepmc   +1 more source

Fab N-Glycosylation in IgG: Implications in Physiological and Pathological Immune Regulation. [PDF]

Biomolecules
Chen S, Yu F, Huang B, Liang G, Xu J, Lin Y, Xu Q.   +6 more
europepmc   +1 more source

Anti-citrullinated protein antibodies may be prognostic factor for vascularization of the synovial membrane in patients with high activity of RA. [PDF]

Rheumatol Int
Jakubaszek M, Kwiatkowska B, Płaza M, Maślińska M.   +3 more
europepmc   +1 more source

Anti-<i>Porphyromonas gingivalis</i> lipopolysaccharide antibody in rheumatoid arthritis patients with emphysema. [PDF]

Front Med (Lausanne)
Oka S, Higuchi T, Shimada K, Fujimori M, Hashimoto A, Komiya A, Saisho K, Yoshikawa N, Suzuki M, Matsui T, Fukui N, Migita K, Tohma S, Furukawa H.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Comparison of serological markers between ACPA+ and ACPA− of RA patients

Rheumatology International, 2011
Anti-citrullinated protein/peptide antibodies (ACPA) have recently emerged as sensitive and specific serological markers of rheumatoid arthritis (RA), providing superior alternative of the rheumatoid factor (RF) test in the laboratory diagnostics of RA. We compare the change of serum RF, CRP, IgG, IgM, IgA, total complement, C3 and C4.
Chunhua, Xun, Yong, Zhao
openaire   +2 more sources

ACPA 2016 Oral Presentation Abstracts

The Cleft Palate-Craniofacial Journal, 2016
The peer-reviewed abstracts presented at the 73rd Annual Meeting of the ACPA are published as submitted by the authors. For financial conflict of interest disclosure, please visit http://meeting.acpa-cpf.org/disclosures.html.
openaire   +3 more sources